|
35748885 |
0 |
Cuker A, Tseng EK, Schunemann HJ, et al.
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
Blood Adv. 2022 Jun 24. pii: 485690. doi: 10.1182/bloodadvances.2022007940.
|
|
35503027 |
0 |
Cuker A, Tseng EK, Nieuwlaat R, et al.
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients.
Blood Adv. 2022 May 3. pii: 485124. doi: 10.1182/bloodadvances.2022007561.
|
|
34727173 |
0 |
Cuker A, Tseng EK, Nieuwlaat R, et al.
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis.
Blood Adv. 2021 Nov 2. pii: 477753. doi: 10.1182/bloodadvances.2021005945.
|
|
34649864 |
0 |
Sholzberg M, Tang GH, Rahhal H, et al.
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400.
|
|
34474482 |
0 |
Cuker A, Tseng EK, Nieuwlaat R, et al.
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients.
Blood Adv. 2021 Oct 26;5(20):3951-3959. doi: 10.1182/bloodadvances.2021005493.
|
|
33691765 |
0 |
Sholzberg M, Tang GH, Negri E, et al.
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
|
|
33560401 |
0 |
Cuker A, Tseng EK, Nieuwlaat R, et al.
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19.
Blood Adv. 2021 Feb 9;5(3):872-888. doi: 10.1182/bloodadvances.2020003763.
|
|
31008430 |
0 |
Tseng EK, Jo D, Shih AW, et al.
Window to the Unknown: Using Storytelling to Identify Learning Needs for the Intrinsic Competencies Within an Online Needs Assessment.
AEM Educ Train. 2019 Jan 6;3(2):179-187. doi: 10.1002/aet2.10315. eCollection 2019 Apr.
|
|
29488097 |
0 |
Chan TM, Jo D, Shih AW, et al.
The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series.
Perspect Med Educ. 2018 Jun;7(3):219-223. doi: 10.1007/s40037-018-0406-0.
|
|
28676580 |
0 |
Tseng E, Selby R.
Testing for heritable thrombophilia in acute venous thromboembolism.
CMAJ. 2017 Jul 4;189(26):E891. doi: 10.1503/cmaj.160062.
|
|
26696619 |
0 |
Tseng E, Crowther MA, Hillis CM.
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation.
CMAJ. 2016 Mar 15;188(5):361-362. doi: 10.1503/cmaj.150867. Epub 2015 Dec 22.
|
, McMaster University